Surveillance of Vaccination Coverage of Inactivated Influenza Vaccines and Allergic Rash Adverse Events Following Immunization for Children From 6 Manufacturers.
The composition of influenza vaccines is updated annually. To ensure vaccine safety, the coverage and adverse events following immunization (AEFI) of 6 manufacturers of trivalent inactivated influenza vaccine (TIV3) need to be evaluated. In January 2022, we analyzed data from more than 1.59 million...
| Publicado en: | Inquiry (00469580) pp. 1 - 13 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , |
| Formato: | Artículo |
| Publicado: |
Sage Publications Inc.
6/26/2023
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=hlh&AN=164554544&site=ehost-live header: @attributes: shortDbName: hlh uiTerm: 164554544 longDbName: Humanities International Complete uiTag: AN controlInfo: bkinfo: jinfo: jid: 00469580 INQ jtl: Inquiry (00469580) issn: 00469580 maglogo: Y pubinfo: dt: 6/26/2023 pid: 344 pub: Sage Publications Inc. artinfo: ui: 164554544 10.1177/00469580231182040 ppf: 1 ppct: 12 formats: tig: atl: Surveillance of Vaccination Coverage of Inactivated Influenza Vaccines and Allergic Rash Adverse Events Following Immunization for Children From 6 Manufacturers. aug: au: Li, Zhi-qun Tan, Hui-feng Zhang, Zhou-bin Jing, Qing-long Zhang, Chun-huan Qin, Zi-qi Ni, Li-Hong Yun, Xue-xia Huang, Yong Chen, Jian Cui, Min Wang, Wen Xu, Jian-xiong Feng, Wen-ru Kang, Yan Tang, Lin affil: Guangzhou Center for Disease Control and Prevention, Guangzhou, China University of Reading, Reading, UK su: Influenza prevention Influenza vaccines Public health surveillance Immunization Fever Confidence intervals Manufacturing industries Age distribution Vaccination coverage Exanthema Retrospective studies Population geography Vaccine effectiveness Sex distribution Descriptive statistics Government policy Medical records Chi-squared test Business Research funding Information storage & retrieval systems Data analysis software Adverse health care events Disease risk factors Children China sug: subj: China Influenza prevention Influenza vaccines Public health surveillance Immunization Fever Confidence intervals Manufacturing industries Age distribution Vaccination coverage Exanthema Retrospective studies Population geography Vaccine effectiveness Sex distribution Descriptive statistics Government policy Medical records Chi-squared test Business Research funding Information storage & retrieval systems Data analysis software Adverse health care events Disease risk factors Children keyword: adverse events following immunization allergic influenza vaccine rash vaccination coverage ab: The composition of influenza vaccines is updated annually. To ensure vaccine safety, the coverage and adverse events following immunization (AEFI) of 6 manufacturers of trivalent inactivated influenza vaccine (TIV3) need to be evaluated. In January 2022, we analyzed data from more than 1.59 million children in the Childhood Vaccination Information Management System and the AEFI Surveillance Information Management System and evaluated influenza vaccines for children aged 6 to 35 months in Guangzhou from 2016/17 to 2019/20 Vaccination rates and AEFI reporting rates. From 2016/17 to 2019/20, the 1-dose influenza vaccination rate was 25.0% (range: 20.7%-30.2%), and the 2-dose (full course) influenza vaccination rate was 21.6% (range: 17.7%-26.4%). The full vaccination coverage rate has trended down since 2017/2018 (2017/18: 26.0%; 2018/19: 8.3; 2019/20: 17.7%). Fifty-two cases (13.1/100 000) and 24 cases (6.9/100 000) received AEFI reports for 1 dose and 2 doses, respectively, mainly due to fever ≥38.6°C (39 cases for 1 dose, 9.8/100 000; 15 cases for 2 dose, 4.3/100 000) and allergic rash (9 cases with 1 dose, 2.3/100 000; 5 cases with 2 doses, 1.4/100 000). Patients who received A and F manufacturers were more likely to report side effects. The safety of influenza vaccines from 6 manufacturers is good, and it is necessary to improve the recommended information on influenza vaccines to dispel people's concerns and increase the vaccination rate. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: Y dt: @attributes: year: 2023 holdings: @attributes: islocal: N |
|---|